Chronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD) is the indication for 21 drugs in DrugBank. It is covered by 40 curated, structured indications.

Also known as: Chronic Kidney Disease · Kidney Disease, Chronic · Chronic Kidney Diseases · Chronic Kidneys Disease · Chronic Kidney Disease(CKD)
Classified under: Urogenital Diseases
Indicated drugs: Aluminum hydroxide
Calcium carbonate
Cinacalcet
Dapagliflozin
Daprodustat
Darbepoetin alfa
Empagliflozin
Erythropoietin
Etelcalcetide
Ferric pyrophosphate citrate
Ferumoxytol
Finerenone
Iron
Metformin
Methoxy polyethylene glycol-epoetin beta
Roxadustat
Semaglutide
Somatotropin
Sotagliflozin
Tenapanor
Tetraferric tricitrate decahydrate

Resolves to

Vocabularies

MeSHM0480472ICD-10N18SNOMED CT197655004MedDRA10009119UMLSC0022661

What you can answer from here — as of October 23, 2026

21Indicated drugsWith each drug's targets and mechanism

Listed above

40Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

1,039Clinical trialsPhase, status and sponsor resolved per trial

1Contraindicated drugDrugs whose labels contraindicate them in this condition

12Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Chronic Kidney Disease (CKD) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.